Vigil Neuroscience, Inc.
A biotechnology company developing potential treatments for neurodegenerative diseases. With a focus on microglia, the central immune cells of the brain, the company is working to treat a rare and fatal neurodegenerative disease called axonal spheroids and pigmented glia (ALSP) as well as larger, more common neurodegenerative diseases such as Alzheimer's disease. Based in Delaware.
Overview
Overview | |
|---|---|
Country | United States |
State | Massachusetts |
Employees | 65 |
Founded | 2020 |
Financials | |
|---|---|
Market Capitalization | 163.49M |
Revenue | |
Operating Income | -89.51M |
Operating Margin | |
Net Income | -82.78M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4733 / 5373 |
Sector : Healthcare | 856 / 1144 |
Industry : Biotechnology | 427 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 3760 / 5565 |
Sector : Healthcare | 626 / 1182 |
Industry : Biotechnology | 323 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4649 / 5436 |
Sector : Healthcare | 857 / 1164 |
Industry : Biotechnology | 436 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4287 / 5330 |
Sector : Healthcare | 737 / 1174 |
Industry : Biotechnology | 322 / 667 |